FIELD: medicine.
SUBSTANCE: what is declared is using Zongorine as a haemostimulating agent.
EFFECT: agent is the high-effective and haemostimulating agent.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HEMOSTIMULATING MEDICATION | 2012 |
|
RU2505308C1 |
HEMOSTIMULATING AGENT | 2013 |
|
RU2514648C1 |
METHOD FOR STIMULATING MYELOGENESIS | 2010 |
|
RU2442589C1 |
MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
PREPARATION PREVENTING DEVELOPMENT OF DEPRESSION OF ERITHROID HEMATOPOIESIS SHOOT WITH INTRODUCTION OF CYTOSTATIC | 2007 |
|
RU2354376C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
METHOD OF STIMULATION IN VITRO PLURIPOTENT HEMOPOETIC STEM CELLS | 2010 |
|
RU2439147C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOIETIN IN A CELL CULTURE in vitro | 2015 |
|
RU2589288C1 |
HAEMOSTIMULATING MEDICATION | 2010 |
|
RU2437675C1 |
Authors
Dates
2014-12-10—Published
2013-10-29—Filed